ID   GLT14_HUMAN             Reviewed;         552 AA.
AC   Q96FL9; B3KV89; Q4ZG75; Q53SU1; Q53TJ0; Q8IVI4; Q9BRH1; Q9H827; Q9H9J8;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 167.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 14;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 14;
DE            Short=GalNAc-T14;
DE            Short=pp-GaNTase 14;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 14;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14;
GN   Name=GALNT14; ORFNames=UNQ2434/PRO4994;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RC   TISSUE=Stomach;
RX   PubMed=12507512; DOI=10.1016/s0006-291x(02)02908-x;
RA   Wang H., Tachibana K., Zhang Y., Iwasaki H., Kameyama A., Chen L.,
RA   Guo J.-M., Hiruma T., Togayachi A., Kudo T., Kikuchi N., Narimatsu H.;
RT   "Cloning and characterization of a novel UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase, pp-GalNAc-T14.";
RL   Biochem. Biophys. Res. Commun. 300:738-744(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wandall H.H., Bennett E.P.;
RL   Submitted (SEP-2011) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-435 (ISOFORM 2).
RC   TISSUE=Fibroblast, Retinoblastoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=20179215; DOI=10.1158/1078-0432.ccr-09-3108;
RA   Stern H.M., Padilla M., Wagner K., Amler L., Ashkenazi A.;
RT   "Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in
RT   clinical trials of dulanermin and drozitumab.";
RL   Clin. Cancer Res. 16:1587-1596(2010).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor. Displays activity
CC       toward mucin-derived peptide substrates such as Muc2, Muc5AC, Muc7, and
CC       Muc13 (-58). May be involved in O-glycosylation in kidney.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:12507512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:12507512};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-
CC       pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96FL9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96FL9-2; Sequence=VSP_011222;
CC       Name=3;
CC         IsoId=Q96FL9-3; Sequence=VSP_011221;
CC       Name=4;
CC         IsoId=Q96FL9-4; Sequence=VSP_045121;
CC   -!- TISSUE SPECIFICITY: Detected in renal tubules (at protein level).
CC       Highly expressed in fetal and adult kidney. Widely expressed at low
CC       level. Weakly expressed in whole brain, cerebellum, thymus, lung,
CC       mammary gland, liver, stomach, small intestine, colon, pancreas,
CC       spleen, bladder, uterus, placenta, testis, ovary, skeletal muscle,
CC       leukocyte, B-cell, bone marrow, fetal brain, fetal thymus, fetal lung,
CC       fetal liver, fetal small intestine, fetal spleen, fetal skeletal and
CC       fetus. Detected in renal tubules (at protein level).
CC       {ECO:0000269|PubMed:12507512, ECO:0000269|PubMed:20179215}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and contributes
CC       to the glycopeptide specificity. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Major isoform.
CC   -!- MISCELLANEOUS: [Isoform 3]: Minor isoform. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14795.1; Type=Miscellaneous discrepancy; Note=Chimeric at the C-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 14;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_497";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB078144; BAC56889.1; -; mRNA.
DR   EMBL; Y09324; CAA70505.4; -; mRNA.
DR   EMBL; AY358758; AAQ89118.1; -; mRNA.
DR   EMBL; AK022753; BAB14227.1; -; mRNA.
DR   EMBL; AK024039; BAB14795.1; ALT_SEQ; mRNA.
DR   EMBL; AK091313; BAC03634.1; -; mRNA.
DR   EMBL; AK122747; BAG53701.1; -; mRNA.
DR   EMBL; AC009301; AAX88899.1; -; Genomic_DNA.
DR   EMBL; AC009305; AAX93209.1; -; Genomic_DNA.
DR   EMBL; AC015980; AAY24301.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00489.1; -; Genomic_DNA.
DR   EMBL; BC006269; AAH06269.2; -; mRNA.
DR   EMBL; BC010659; AAH10659.1; -; mRNA.
DR   CCDS; CCDS1773.2; -. [Q96FL9-1]
DR   CCDS; CCDS58705.1; -. [Q96FL9-4]
DR   CCDS; CCDS58706.1; -. [Q96FL9-3]
DR   RefSeq; NP_001240755.1; NM_001253826.1. [Q96FL9-3]
DR   RefSeq; NP_001240756.1; NM_001253827.1. [Q96FL9-4]
DR   RefSeq; NP_001316024.1; NM_001329095.1.
DR   RefSeq; NP_001316025.1; NM_001329096.1. [Q96FL9-4]
DR   RefSeq; NP_078848.2; NM_024572.3. [Q96FL9-1]
DR   AlphaFoldDB; Q96FL9; -.
DR   SMR; Q96FL9; -.
DR   BioGRID; 122753; 48.
DR   IntAct; Q96FL9; 2.
DR   BindingDB; Q96FL9; -.
DR   ChEMBL; CHEMBL4523427; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   GlyGen; Q96FL9; 3 sites, 3 O-linked glycans (3 sites).
DR   iPTMnet; Q96FL9; -.
DR   PhosphoSitePlus; Q96FL9; -.
DR   BioMuta; GALNT14; -.
DR   DMDM; 51316071; -.
DR   EPD; Q96FL9; -.
DR   MassIVE; Q96FL9; -.
DR   MaxQB; Q96FL9; -.
DR   PaxDb; Q96FL9; -.
DR   PeptideAtlas; Q96FL9; -.
DR   PRIDE; Q96FL9; -.
DR   ProteomicsDB; 3748; -.
DR   ProteomicsDB; 76541; -. [Q96FL9-1]
DR   ProteomicsDB; 76542; -. [Q96FL9-2]
DR   ProteomicsDB; 76543; -. [Q96FL9-3]
DR   Antibodypedia; 2530; 227 antibodies from 24 providers.
DR   DNASU; 79623; -.
DR   Ensembl; ENST00000324589.9; ENSP00000314500.5; ENSG00000158089.15. [Q96FL9-3]
DR   Ensembl; ENST00000349752.10; ENSP00000288988.6; ENSG00000158089.15. [Q96FL9-1]
DR   Ensembl; ENST00000406653.5; ENSP00000385435.1; ENSG00000158089.15. [Q96FL9-4]
DR   GeneID; 79623; -.
DR   KEGG; hsa:79623; -.
DR   MANE-Select; ENST00000349752.10; ENSP00000288988.6; NM_024572.4; NP_078848.2.
DR   UCSC; uc002rnq.4; human. [Q96FL9-1]
DR   CTD; 79623; -.
DR   DisGeNET; 79623; -.
DR   GeneCards; GALNT14; -.
DR   HGNC; HGNC:22946; GALNT14.
DR   HPA; ENSG00000158089; Tissue enhanced (kidney).
DR   MIM; 608225; gene.
DR   neXtProt; NX_Q96FL9; -.
DR   OpenTargets; ENSG00000158089; -.
DR   PharmGKB; PA134920089; -.
DR   VEuPathDB; HostDB:ENSG00000158089; -.
DR   GeneTree; ENSGT00940000158182; -.
DR   HOGENOM; CLU_013477_0_2_1; -.
DR   InParanoid; Q96FL9; -.
DR   OMA; QLCLSVH; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q96FL9; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   PathwayCommons; Q96FL9; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SignaLink; Q96FL9; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 79623; 7 hits in 1059 CRISPR screens.
DR   ChiTaRS; GALNT14; human.
DR   GeneWiki; GALNT14; -.
DR   GenomeRNAi; 79623; -.
DR   Pharos; Q96FL9; Tchem.
DR   PRO; PR:Q96FL9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q96FL9; protein.
DR   Bgee; ENSG00000158089; Expressed in lower esophagus mucosa and 126 other tissues.
DR   ExpressionAtlas; Q96FL9; baseline and differential.
DR   Genevisible; Q96FL9; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IBA:GO_Central.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Glycosyltransferase; Golgi apparatus;
KW   Lectin; Manganese; Membrane; Metal-binding; Reference proteome;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..552
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 14"
FT                   /id="PRO_0000059133"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..26
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        27..552
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          415..550
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          110..215
FT                   /note="Catalytic subdomain A"
FT   REGION          274..336
FT                   /note="Catalytic subdomain B"
FT   BINDING         151
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         176
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         199
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         200
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         201
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         305
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         333
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         336
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         339
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         341
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   DISULFID        101..328
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        319..397
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        430..449
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        476..493
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        517..538
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   VAR_SEQ         1..43
FT                   /note="MRRLTRRLVLPVFGVLWITVLLFFWVTKRKLEVPTGPEVQTPK -> MSFPM
FT                   SLARSSVPFADSGLSSSQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045121"
FT   VAR_SEQ         44..99
FT                   /note="PSDADWDDLWDQFDERRYLNAKKWRVGDDPYKLYAFNQRESERISSNRAIPD
FT                   TRHL -> VWSLFFKVAGMSPWAPQVPVSPTPPYQRGHLPTGGHLAVCHFPCLLQEAQF
FT                   HLQTQVFLQV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011221"
FT   VAR_SEQ         100..132
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011222"
FT   VARIANT         469
FT                   /note="Q -> K (in dbSNP:rs2288101)"
FT                   /id="VAR_033948"
FT   CONFLICT        368
FT                   /note="Q -> R (in Ref. 4; BAB14795)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   552 AA;  64321 MW;  6F2ABAA89F482696 CRC64;
     MRRLTRRLVL PVFGVLWITV LLFFWVTKRK LEVPTGPEVQ TPKPSDADWD DLWDQFDERR
     YLNAKKWRVG DDPYKLYAFN QRESERISSN RAIPDTRHLR CTLLVYCTDL PPTSIIITFH
     NEARSTLLRT IRSVLNRTPT HLIREIILVD DFSNDPDDCK QLIKLPKVKC LRNNERQGLV
     RSRIRGADIA QGTTLTFLDS HCEVNRDWLQ PLLHRVKEDY TRVVCPVIDI INLDTFTYIE
     SASELRGGFD WSLHFQWEQL SPEQKARRLD PTEPIRTPII AGGLFVIDKA WFDYLGKYDM
     DMDIWGGENF EISFRVWMCG GSLEIVPCSR VGHVFRKKHP YVFPDGNANT YIKNTKRTAE
     VWMDEYKQYY YAARPFALER PFGNVESRLD LRKNLRCQSF KWYLENIYPE LSIPKESSIQ
     KGNIRQRQKC LESQRQNNQE TPNLKLSPCA KVKGEDAKSQ VWAFTYTQQI LQEELCLSVI
     TLFPGAPVVL VLCKNGDDRQ QWTKTGSHIE HIASHLCLDT DMFGDGTENG KEIVVNPCES
     SLMSQHWDMV SS
//
